West Pharmaceutical Services return on tangible equity for the quarter ending March 31, 2025 was 19.27.
West Pharmaceutical Services average return on tangible equity for 2023 was 21.5, a 26.52% decline from 2022.
West Pharmaceutical Services average return on tangible equity for 2022 was 29.26, a 5.03% decline from 2021.
West Pharmaceutical Services average return on tangible equity for 2021 was 30.81, a 47.98% decline from 2020.
Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.